Matrix Partners China

Investments by market, targeted sectors and preferred funding rounds

Name - Matrix Partners China
Web -
Description -
Investor Type -
Preferred rounds -
Location

Investments by industry

healthtech - 17%
travel - 17%
dev software - 17%
biotech - 33%
data - 17%

Number of investments: 6

Matrix Partners China invested in OnQuality Pharmaceuticals during a round worth $35,000,000 - 3/31/2021
Matrix Partners China invested in Klook during a round worth $200,000,000 - 1/26/2021
Matrix Partners China invested in vesoft during a round worth $10,000,000 - 12/16/2020
Matrix Partners China invested in Tallac Therapeutics during a round worth $62,000,000 - 12/1/2020
Matrix Partners China invested in D3 Bio during a round worth $200,000,000 - 11/18/2020
Matrix Partners China invested in PingCAP during a round worth $270,000,000 - 11/17/2020